Helmut Albrecht Selected Research

Helmut Albrecht Research Topics

Disease

13	Infections 01/2022 - 06/2010
12	Sepsis (Septicemia) 07/2019 - 01/2015
6	COVID-19 01/2022 - 01/2020
3	Pneumonia (Pneumonitis) 01/2021 - 07/2011
2	Inflammation (Inflammations) 01/2022 - 12/2020
2	Dyslipidemias (Dyslipidemia) 01/2020 - 12/2013
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019 - 12/2012
2	Bacteremia 01/2018 - 01/2018
2	Hypersensitivity (Allergy) 04/2016 - 10/2007
2	Acquired Immunodeficiency Syndrome (AIDS) 11/2015 - 02/2008
2	Virus Diseases (Viral Diseases) 06/2010 - 03/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Wounds and Injuries (Trauma) 01/2020
1	Chronic Hepatitis B 01/2019
1	Adenocarcinoma 01/2019
1	Cough 01/2019
1	Headache (Headaches) 01/2019
1	Heart Arrest (Cardiac Arrest) 01/2019
1	Heart Diseases (Heart Disease) 01/2019
1	Heart Failure 01/2019
1	Lymphoma (Lymphomas) 01/2019
1	Pulmonary Embolism 01/2019
1	Opportunistic Infections (Opportunistic Infection) 01/2018
1	Critical Illness (Critically Ill) 11/2017
1	Urinary Tract Infections (Urinary Tract Infection) 01/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2016
1	Diabetes Mellitus 04/2016
1	Hepatitis 02/2013
1	Obstructive Lung Diseases (Obstructive Lung Disease) 07/2011
1	Legionnaires' Disease (Legionnaire's Disease) 07/2011
1	Drug-Related Side Effects and Adverse Reactions 07/2011

Drug/Important Bio-Agent (IBA)

5	FluoroquinolonesIBA 01/2017 - 07/2011
3	Pharmaceutical PreparationsIBA 01/2022 - 02/2011
2	AntibodiesIBA 01/2022 - 06/2021
2	Immunoglobulin G (IgG)IBA 01/2022 - 06/2021
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2020
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 12/2020
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 12/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 12/2020
2	Guaifenesin FDA LinkGeneric 01/2019 - 12/2012
2	dolutegravirIBA 01/2019 - 11/2013
2	Antiviral Agents (Antivirals)IBA 01/2019 - 03/2010
2	TabletsIBA 01/2019 - 01/2019
2	beta-LactamsIBA 03/2018 - 04/2016
2	LactamsIBA 01/2017 - 01/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2016 - 12/2004
1	von Willebrand FactorIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022
1	ArginaseIBA 01/2022
1	Protein SIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	CytokinesIBA 01/2022
1	IgA receptor (protein B)IBA 01/2022
1	Histones (Histone)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 08/2021
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 08/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2021
1	Nucleic AcidsIBA 06/2021
1	Immunoglobulin M (IgM)IBA 06/2021
1	DNA (Deoxyribonucleic Acid)IBA 06/2021
1	Nucleocapsid ProteinsIBA 06/2021
1	oxidized low density lipoproteinIBA 01/2020
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020
1	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 07/2019
1	Cefazolin (Ancef)FDA LinkGeneric 07/2019
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 07/2019
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 07/2019
1	tenofovir alafenamideIBA 01/2019
1	Emtricitabine (Emtriva)FDA Link 01/2019
1	Tenofovir (Viread)FDA Link 01/2019
1	Expectorants (Mucolytics)IBA 01/2019
1	bictegravirIBA 01/2019
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 11/2017
1	Cefepime (Maxipime)FDA LinkGeneric 11/2017
1	NucleosidesIBA 12/2013
1	Protease Inhibitors (Protease Inhibitor)IBA 12/2013
1	Reverse Transcriptase InhibitorsIBA 12/2013
1	Raltegravir Potassium FDA Link 11/2013
1	Rilpivirine (TMC-278)IBA 02/2013
1	Ciprofloxacin (Cipro)FDA LinkGeneric 07/2011
1	Rifampin (Rifampicin)FDA LinkGeneric 07/2011
1	Erythromycin (Erycette)FDA LinkGeneric 07/2011
1	Clarithromycin (Biaxin)FDA LinkGeneric 07/2011

Therapy/Procedure

14	Therapeutics 01/2022 - 12/2004
2	Art Therapy 01/2018 - 02/2011
2	Retention in Care 01/2018 - 11/2015
1	Duration of Therapy 10/2017
1	Vascular Access Devices (Arterial Line) 05/2017
1	Length of Stay 01/2017
1	Renal Dialysis (Hemodialysis) 12/2016
1	Central Venous Catheters 12/2014
1	Total Parenteral Nutrition 12/2014
1	Catheters 12/2014
1	Highly Active Antiretroviral Therapy (HAART) 12/2013